Investing
Top Analyst Upgrades and Downgrades: Accenture, Ericsson, GM, Phillips 66, United Rentals, Urban Outfitters, Xerox, Yum and More
October 3, 2017 9:05 am
Last Updated: March 20, 2020 11:20 am
AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) was started as Buy and assigned a $10 price target (versus a $5.50 close) at H.C. Wainwright.
Changyou.com Ltd. (NASDAQ: CYOU) was started as Neutral with a $40 price target (versus a $40.14 close) at Credit Suisse.
Chipotle Mexican Grill Inc. (NYSE: CMG) was started as Hold with a $345 price target (versus a $301.81 close) at Stifel.
Craft Brew Alliance Inc. (NASDAQ: BREW) was started as Positive with a $22 price target (versus a $17.80 close) at Susquehanna.
Endocyte Inc. (NASDAQ: ECYT) was raised to Outperform from Neutral with a $7 price target (versus a $3.63 close) at Wedbush Securities. The firm noted that in-licensing of its Phase 3 ready asset has improved its outlook with peak sales potentially at about $1 billion.
Lear Corp. (NYSE: LEA) was downgraded to Neutral from Buy with a $182 price target (versus a $175.04 close) at UBS.
LGI Homes Inc. (NASDAQ: LGIH) was downgraded to Neutral from Outperform with a $49 price target (versus a $48.98 close) at Wedbush, noting that its price target had been met.
Manhattan Associates Inc. (NASDAQ: MANH) was raised to Buy from Hold with a $55 price target (versus a $43.20 close) at SunTrust Robinson Humphrey.
Marathon Petroleum Corp. (NYSE: MPC) was downgraded to Neutral from Buy at Goldman Sachs.
Masonite International Corp. (NYSE: DOOR) was downgraded to Neutral from Outperform with a $70 price target (versus a $68.70 close) at Wedbush. This downgrade was a valuation call within 5% of its target.
Neurocrine Biosciences Inc. (NASDAQ: NBIX) was reiterated as Buy and the price target was raised to $69 from $66 (versus a $61.82 close) at Jefferies. The firm’s latest doctor survey predicts that Ingrezza will continue to lead the market share in Tardive Dyskinesia (TD).
Rex Energy Corp. (NASDAQ: REXX) was downgraded to Sector Perform from Outperform with a $3 price target (versus a $2.62 close) at RBC Capital Markets.
Tyson Foods Inc. (NYSE: TSN) was reiterated as Buy and the price target was raised to $82 from $75 (versus a $70.99 close) at Jefferies.
Monday’s top analyst upgrades and downgrades were in AbbVie, Baker Hughes, CSX, Micron Technology, Nucor, PepsiCo, Western Digital and many more.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.